Related Experiment Videos
Health services in rheumatology
1Veterans Affairs Palo Alto Health Care System, Department of Medicine, Stanford University School of Medicine, Palo Alto, California 94304, USA.
Current Opinion in Rheumatology
|April 6, 2000
Summary
Rheumatic disease costs are linked to functional disability. Access to rheumatology care, especially for elderly patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), is limited and impacts outcomes.
Area of Science:
- Rheumatology
- Health Services Research
- Medical Economics
Background:
- Rheumatic diseases represent a significant healthcare burden.
- Understanding rheumatology practice patterns and patient access is crucial for optimizing care.
- The relationship between healthcare delivery and patient outcomes in rheumatology requires investigation.
Purpose of the Study:
- To review studies on the costs, referral patterns, practice dynamics, and outcome correlations in rheumatic diseases.
- To analyze direct medical costs in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).
- To assess patient access to rheumatology subspecialty care and its impact on health status and mortality.
Main Methods:
- Review of existing studies on rheumatic disease costs, patient referrals, and practice patterns.
- Analysis of direct medical costs in RA and SLE patients across different healthcare systems.
- Examination of factors influencing access to rheumatology care, including demographics and disease severity.
Main Results:
- Direct medical costs for RA correlate with functional disability.
- SLE medical costs show no significant difference across varied international healthcare financing systems.
- Primary care diagnostic accuracy for rheumatic complaints may be low; access to rheumatologists is limited for certain demographics, particularly elderly black women with RA or SLE.
Conclusions:
- Early access to rheumatology subspecialty care may improve health status in RA patients.
- Hospital experience in treating SLE correlates with patient mortality rates.
- Addressing disparities in access to rheumatology care is essential for improving patient outcomes.